Please ensure Javascript is enabled for purposes of website accessibility

Cerner Corporation Cuts 2018 Outlook on Weak First Quarter

By Keith Speights – May 3, 2018 at 5:34AM

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The delay of a major contract contributed to the healthcare technology leader missing its first-quarter revenue forecast.

Cerner Corporation's (CERN) sales growth was unimpressive when the company reported its 2017 fourth-quarter results in February. There was a hint of better growth ahead, though, with Cerner posting record-high bookings.

That better growth appears to be still in the future, however. Cerner announced its 2018 first-quarter results after the market closed on Wednesday. Here are the highlights. 

Medical staff in hallway of hospital.

Image source: Cerner.

Cerner results: The raw numbers


Q1 2018 

Q1 2017 

Year-Over-Year Change


$1.29 billion $1.26 billion


Net income from continuing operations

$160 million $173.2 million


Adjusted earnings per share (EPS)

$0.58 $0.59


Data source: Cerner.

What happened with Cerner this quarter?

The good news for Cerner in the first quarter was that it enjoyed solid growth in three key areas. Professional services revenue increased more than 11% year over year to $441.3 million. Managed services revenue grew 3% over the prior-year period to $268.3 million. Support and maintenance revenue climbed 8.6% year over year to $284.6 million.

However, Cerner also posted sales declines in other categories. Sales of licensed software fell 5% from the prior-year period to $134.8 million. Revenue from subscriptions plunged 32% year over year to $76.6 million. Technology resale revenue slipped 1% from the first quarter of 2017 to $63.4 million. In total, Cerner's first-quarter revenue fell below its previous guidance of $1.315 billion to $1.365 billion. 

Cerner's GAAP net income was helped by U.S. corporate tax reform. The company paid nearly $30 million less in taxes than it did in the same quarter of last year. However, that wasn't enough to offset significant spending increases. Operating expenses grew 6% year over year to $866.4 million. Still, Cerner's adjusted EPS in the first quarter matched the mid-point of the guidance range the company gave in February.

Once again, Cerner recorded solid bookings, which represent the amount of prospective revenue from contracts signed but not yet implemented. First-quarter bookings were just under $1.4 billion, bringing Cerner's total backlog to $14.6 billion.

What management had to say

Cerner president Zane Burke said, "Our results in the first quarter included strong bookings and cash flow and in-line earnings, but our revenue was below expected levels." He added, "Our mixed results and revised outlook reflect the delay of a large contract and a less predictable end market. However, we remain optimistic about our long-term growth opportunities due to our strong market position and portfolio of solutions and tech-enabled services that align with the pressures healthcare stakeholders are facing."

Looking forward

Cerner expects revenue to pick up a bit in the second quarter. The company projects second-quarter revenue between $1.31 billion and $1.36 billion. However, because of the weaker-than-expected first quarter, Cerner lowered its full-year 2018 revenue outlook. The company now expects full-year revenue between $5.325 billion and $5.45 billion, down from $5.45 billion to $5.65 billion.

The company also projects second-quarter adjusted EPS between $0.59 and $0.61, which would reflect a slight year-over-year decline at the mid-point of the range. Full-year 2018 adjusted EPS is expected to be between $2.45 and $2.55, down from Cerner's previous guidance of $2.57 to $2.73.

Some of Cerner's weakness should only be temporary. As Zane Burke mentioned, the delay of a large contract weighed on the company's performance in the first quarter. The challenge for Cerner will be to convert its bookings backlog into implementations that generate solid revenue. Overall, though, the company's business continues to look sound.


Keith Speights has no position in any of the stocks mentioned. The Motley Fool recommends Cerner. The Motley Fool has a disclosure policy.

Invest Smarter with The Motley Fool

Join Over 1 Million Premium Members Receiving…

  • New Stock Picks Each Month
  • Detailed Analysis of Companies
  • Model Portfolios
  • Live Streaming During Market Hours
  • And Much More
Get Started Now

Stocks Mentioned

Cerner Corporation Stock Quote
Cerner Corporation

*Average returns of all recommendations since inception. Cost basis and return based on previous market day close.

Related Articles

Motley Fool Returns

Motley Fool Stock Advisor

Market-beating stocks from our award-winning analyst team.

Stock Advisor Returns
S&P 500 Returns

Calculated by average return of all stock recommendations since inception of the Stock Advisor service in February of 2002. Returns as of 09/24/2022.

Discounted offers are only available to new members. Stock Advisor list price is $199 per year.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.